Gayl Reader, MD
Cardiovascular Disease · Greenville, KYNPI 1467401729
Payments from drug & device makers
Across 565 payments — averaging $47.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$20K
- Novartis$2K
- Johnson & Johnson$958
- Merck$800
- Boehringer Ingelheim$712
- AstraZeneca$507
- plus $2K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 106 | $19,884 |
| Novartis | 146 | $1,926 |
| Johnson & Johnson | 71 | $958 |
| Merck | 45 | $800 |
| Boehringer Ingelheim | 45 | $712 |
| AstraZeneca | 23 | $507 |
| Pfizer | 28 | $473 |
| E.r. Squibb & Sons, L.L.C. | 21 | $313 |
| Amarin Pharma, Inc. | 20 | $228 |
| Esperion Therapeutics, Inc. | 11 | $191 |
| Sanofi-aventis U.S. LLC | 9 | $148 |
| Lexicon Pharmaceuticals, Inc. | 6 | $121 |
| Bayer | 6 | $117 |
| Scpharmaceuticals Inc. | 3 | $98 |
| Abiomed | 4 | $90 |
| Medtronic | 1 | $53 |
| Novo Nordisk | 3 | $45 |
| Boston Scientific | 2 | $42 |
| Amryt Pharma Holdings Ltd | 2 | $39 |
| Lundbeck LLC | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Terumo Medical Corporation | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Abbott | 1 | $16 |
| Chiesi USA, Inc. | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Aegerion Pharmaceuticals, Inc. | 1 | $12 |
| Biosense Webster, Inc. | 1 | $12 |
How this compares
$26,944 in reported general payments places this provider in the 85th percentile of 258 cardiovascular disease providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Greenville
- Kishor VoraOwensboro$4.5M
- Dinesh KalraLouisville$739K
- Amir PirachaLouisville$590K
- Rohan SamsonLouisville$527K
- Shahab GhafghaziLouisville$404K
- William SkinnerLexington$346K
- Vipul PanchalLouisville$301K
- John KotterLexington$241K
- John HarrisLouisville$226K
- Suresh SharmaLexington$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.